|
FRRS1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.063700000001E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.215700E-03 |
| Normal-vs-Stage2 |
1.667970E-01 |
| Normal-vs-Stage3 |
2.158300E-03 |
| Normal-vs-Stage4 |
1.502200E-02 |
| Stage1-vs-Stage2 |
7.255000E-01 |
| Stage1-vs-Stage3 |
1.679030E-01 |
| Stage1-vs-Stage4 |
1.210370E-01 |
| Stage2-vs-Stage3 |
2.044800E-01 |
| Stage2-vs-Stage4 |
1.179350E-01 |
| Stage3-vs-Stage4 |
4.329600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.67290999999459E-05 |
| Normal-vs-AfricanAmerican |
5.960400E-01 |
| Normal-vs-Asian |
1.804370E-02 |
| Caucasian-vs-AfricanAmerican |
3.637000E-04 |
| Caucasian-vs-Asian |
8.605800E-01 |
| AfricanAmerican-vs-Asian |
7.141600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.59237999999284E-05 |
| Normal-vs-Female |
6.722100E-02 |
| Male-vs-Female |
6.695600E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.975600E-01 |
| Normal-vs-Age(41-60Yrs) |
3.035900E-03 |
| Normal-vs-Age(61-80Yrs) |
5.97689999999318E-05 |
| Normal-vs-Age(81-100Yrs) |
9.854200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.372400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.085200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.281800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.594400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.562400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.757200E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.521800E-01 |
| Normal-vs-Grade 2 |
3.901000E-03 |
| Normal-vs-Grade 3 |
2.965500E-04 |
| Normal-vs-Grade 4 |
1.928210E-02 |
| Grade 1-vs-Grade 2 |
3.016600E-01 |
| Grade 1-vs-Grade 3 |
4.933900E-02 |
| Grade 1-vs-Grade 4 |
3.964100E-02 |
| Grade 2-vs-Grade 3 |
1.275800E-01 |
| Grade 2-vs-Grade 4 |
1.183040E-01 |
| Grade 3-vs-Grade 4 |
3.196400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.152370E-02 |
| Normal-vs-ccB subtype |
1.53446999999751E-05 |
| ccA subtype-vs-ccB subtype |
2.917900E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.89890000000493E-05 |
| Normal-vs-N1 |
1.561370E-01 |
| N0-vs-N1 |
9.057800E-01 |
|
|
